Author Information
Miguel Alejandro Pinzón is a researcher affiliated with the Infectious Diseases Department at Clínica Medellín Grupo Quirónsalud, Nueva Clínica Sagrado Corazón, and Clínica Panamericana, located in Medellín, Colombia. His work primarily focuses on infectious diseases, particularly in the context of COVID-19 and other related health challenges.
Research Contributions
Miguel Alejandro Pinzón has made significant contributions to the field of infectious diseases, with a particular focus on COVID-19. His research includes critical studies on the effectiveness of corticosteroids such as dexamethasone and methylprednisolone in treating COVID-19 pneumonia. He has also explored atypical manifestations of COVID-19, such as pulmonary cystic disease, and has been involved in antimicrobial stewardship programs. His work not only addresses treatment efficacy but also the broader clinical outcomes of patients with COVID-19, contributing valuable insights to the medical community during the pandemic.
Aliases
Miguel Alejandro Pinzón is known by several aliases, including Miguel A. Pinzon, Miguel A Pinzón, Miguel Pinzón, and Miguel A. Pinzón.
Publication and Citation Metrics
| Metric |
Value |
| Total Citations |
231 |
| H-index |
6 |
| Total Papers |
13 |
